Technology
Nanomedicine
| Publication Date | July 2009 |
| Publisher | Global Industry Analysts |
| Product Type | Report |
| Pages | 698 |
| ISBN Number | not applicable |
| Product Code | GIA00216 |
Price
£2,630.00
approximately: $3,952 | €2,883
approximately: $3,952 | €2,883
Order above formats by FAX
Summary
This report analyzes the Global Market for Nanomedicine in Millions of US$ by the following Application Areas: Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials, and Others. Annual forecasts are provided for the period of 2006 through 2015. The report profiles 263 companies including many key and niche players worldwide such as Abraxis BioScience, Inc., Acusphere, Inc., Advion Biosciences, Inc., Agilent Technologies, Inc., AMAG Pharmaceuticals, Inc., Amgen, Inc., Arrowhead Research Corporation, Calando Pharmaceuticals, Inc., Nanotope, Inc., Tego BioSciences Corporation, BioForce Nanosciences, Inc., BioSante Pharmaceuticals, Inc., Crucell N.V., Elan Corporation Plc, Elan Drug Technologies, Ensysce Biosciences, Inc., Enzon Pharmaceuticals, Inc., eSpin Technologies, Inc., Flamel Technologies S.A., Johnson & Johnson, Life Technologies Corporation, Merck & Co., Inc., Nanobiotix, NanoCarrier Co., Ltd., Nanospectra Biosciences, Inc, Nanosphere, Inc., Nanosys, Inc., Nektar Therapeutics, Novavax, Inc., Oxonica Plc, Par Pharmaceutical Companies, Inc, pSivida Limited, Starpharma Holdings Limited, Dendritic Nanotechnologies, Inc., Starpharma Pty. Ltd., and Wyeth Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Contents
- I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- Drug Delivery
- In Vitro Diagnostics
- In Vivo Imaging
- Biomaterials
- Others
- II. EXECUTIVE SUMMARY
- 1.INDUSTRY OVERVIEW
- Introduction
- Current and Future Analysis
- Industry Drivers
- Industry Challenges
- Developing World Ready to Adopt Nanomedicine in a Major Way
- India
- China
- Japan
- Taiwan
- Nanotechnology Based Medical Products
- Table 1: Global Nanomedicine Market (2007): Percentage Breakdown of Number of Nano-Based Products by Application Area - Drug Delivery, Biomaterials, In Vivo Imaging, and Others (includes corresponding Graph/Chart)
- Nanotechnology Based Drug Delivery Products
- Table 2: Global Nanomedicine Market (2007): Percentage Breakdown of Number of Nano-Based Drug Delivery Products by Category - Liposomes, Nanocristals, Virosomes, and Others (includes corresponding Graph/Chart)
- Nanomedicine Patent Filings
- Table 3: Global Nanomedicine Market (1993-2003): Percentage Breakdown of Nanomedicine Patents by Application Area - Drug Delivery, In Vitro Diagnostics, Imaging, Biomaterials, and Others (includes corresponding Graph/Chart)
- Table 4: Global Nanomedicine Market (1993-2003): Percentage Breakdown of Patents by Country - US, Germany, Japan, and Others (includes corresponding Graph/Chart)
- 2.TRENDS & ISSUES
- Nanomedicine - The Future Direction
- Transforming Healthcare Sector Generating Demand for Nanomedicine
- Nanobiotechnology - A Promising Area
- High Demand for Tiny Healthcare Devices
- Research in Nanomedicine Continues to Surge
- Nanotechnology in Healthcare to Sustain R&D Funding
- Nanomedicine Clinical Pipeline to Sustain the Momentum
- Nanotechnology Gaining Ground in Fast Growing Drug Delivery Market
- Nanotechnology - Generating More Enthusiasm Among Entrants
- Demand for Supplies and Devices to Grow Rapidly
- Nanomedicine Needs Analysis of Ethical Implications
- Nanotechnology-based Drug Delivery Market on an Upbeat
- Nanotechnology Opens Up New Frontiers in Drug Discovery
- Nanotechnology Raises Hope for Tuberculosis Treatment
- Demand for Nano-Based Medical Products to Rise Significantly
- Medical Nanorobotics to Raise the Standards
- Nanomedicine - A Useful Element in Surgical Procedures
- Nano-based Diagnosis and Medical Imaging Helps Treatment of Critical Diseases
- More Efficient Nanoparticles Could be Made Possible by Modeling Software
- Major Issues Daunting Nanomedicine Sector
- 3.PRODUCT/TECHNOLOGY OVERVIEW
- Nanomedicine - A Primer
- Nanopores
- Radio-Controlled Biomolecules
- Quantum Dots
- Nanotubes
- Fullerenes
- Nanoshells
- Nanoprobes
- Nanoparticles
- Ceramic Nanoparticles
- Solid Lipid Nanoparticles
- Nanocapsules
- Dendrimers
- Liposomes
- Micelles
- Nanosuspensions
- Liquid Crystals
- Hydrogels
- Polymeric Nanoparticles
- Molecularly Imprinted Polymers
- 4.APPLICATIONS
- Drug Delivery
- Targeted Nanodrug Delivery & Release
- Active and Passive Targeting Mechanisms in Drug Delivery
- Sustained and Pulsatile Release Mechanisms in Drug Delivery
- In Vitro Diagnostics
- In Vivo Imaging
- Biomaterials
- Others
- Drugs and Therapy
- Active Medical Implants
- Oncology
- Key Applications in Cancer Therapy
- Advanced Imaging, Early-Stage Detection, and Targeting
- In-vivo Imaging
- Effective Tracking of Process Efficiency
- Advancing Bioinformatics and Proteomics Research
- Carbon Nanotubes in Cancer Treatment
- Regenerative Medicine
- Futuristic Applications
- Bio-molecular Motors
- Genetic and Tissue Engineering
- External Tissue Products
- Internal Tissue Implants
- Dental and Bone Replacement
- Protein and Gene Analysis
- Nanorobot Therapeutics
- Lab-on-a-Chip Techniques
- Medical Diagnostic Sensors
- Nano Medical Devices - From Surgical Tools to Contact Lenses
- Nanoengineered Prosthetics
- Nanotubes - Potential Drug Delivery Vehicles
- 5.NANOTECHNOLOGY - AN OVERVIEW
- Building Blocks of Nanotechnology Used, Components and Final End-Use Products
- Global Nanotechnology Market
- Table 5: Global Nanotechnology Market (2008 & 2009): Percentage Breakdown of Revenues by End-Use Segments - Chemicals, Automotive, Aerospace & Defense, Semi-Conductors & Electronics, Nanomedicine and Others (includes corresponding Graph/Chart)
- Commercial Applications at an Embryonic Stage
- Recent Commercial Applications of Nanotechnology
- Nanotech Players - Germany Tops Europe While China Leads Asia-Pacific
- Table 6: Nanotech Companies in Europe (2007): Number of Players in Major Regional Markets - Germany, United Kingdom, Switzerland, France, and Sweden (includes corresponding Graph/Chart)
- Table 7: Nanotech Companies in Asia-Pacific (2007): Number of Players in Major Regional Markets - China, South Korea, Japan, Australia, and Taiwan (includes corresponding Graph/Chart)
- Nanotech Funding by Regional Governments
- Table 8: Nanotech Funding by Regional Governments (2008): Leading National Markets Ranked by Funding in US$ Million for United States, Japan, Russia, Germany and China (includes corresponding Graph/Chart)
- 6.TECHNOLOGICAL DEVELOPMENTS
- German Scientists Develop Nanoparticle-Driven Gene Transfer Method
- Oxford Sees Progress in its Novel DNA Sequencing Technology Project
- Philips Releases First 3D Imaging Findings
- Researchers in University of Pennsylvania Invent Novel Carbon Nanopipette
- UCLA Scientists Develop Localized and Controlled Drug Delivery Method
- Minerva Makes New Discovery in Cancer Treatment
- NanoBio Releases Positive Data with NB-002
- NanoBio Receives Positive Pre-Clinical Results with Intranasal Influenza Vaccine
- Abraxis Announces Interim Results of Abraxane for Metastatic Breast Cancer
- Abraxis Reveals Positive Data with Abraxane and Gemzar
- BioDelivery Commences Clinical Study with Bioral Amphotericin B
- NanoCarrier Develops Protein Nanoencapsulation Technology
- Flamel Releases Positive Preliminary Data from FT-105 Phase I Study
- Abraxis Releases Positive Pre-Clinical Data with nabTechnology Platform and SPARC Expression in Cancer Treatment
- American Scientists Develop Unique Nano-Based Drug Delivery System
- Researchers at University of Queensland Focus to Develop Novel Nano-based Diagnostics for Cancer Detection
- Indian Researchers Synthesize Polymeric Nanocurcumin for Cancer Therapy
- Researchers Mull on Using Nanoparticles to Develop Anti-Tumor Vaccines
- Nanomedicine Creates New Avenues for Regeneration of Nerve Cells
- University of Illinois Develop Enhanced Biomimetic Membranes
- Johns Hopkins Faculty develop Nanoparticle-Embedded Microcapsules
- Max Planck Research Team Develops Gold Nanoparticles
- Nanotechnology based Panacea for Facial Wrinkles
- 7.PRODUCT INTRODUCTIONS/INNOVATIONS
- Starpharma Holdings Releases the NanoJuiceTransfection Kit
- Telomolecular Introduces Nano-Based Aging Solution
- CytoViva Unveils Advanced Nanotechnology Research Tool
- eBioscience Introduces eFluorBrand
- eBioscience Launches eFluorNanocrystals
- BioForce Nanosciences Unveils Surface Patterning Service
- Eastman Kodak Unveils KODAK X-SIGHT Imaging Agents
- Biomet Launches NanoTite Dental Implant
- Deerac Introduces Equator HTS/2 Liquid Handling Solution
- IMEC Develops Functionalized Magnetic Nanoparticles
- Ivoclar Vivadent Introduces New Version of Tetric Flow
- Calando to Begin Human Clinical Trials for siRNA-based Therapeutic Drug for Cancer
- Dabur Pharma Launches Nano-Based Drug Delivery System
- 8.RECENT INDUSTRY ACTIVITY
- APR Acquires New Drug Delivery Platform
- Merck Inks Merger Agreement with Schering-Plough
- Nanobiotix to Collaborate with SonoDrugs Project Consortium
- Liquidia and Abbott to Jointly Develop siRNA Therapeutics
- Pro-Tect Acquires Medivices' Nanotechnology Method
- APR to Create Dedicated Nanotechnology Unit
- Agilent Takes Over Nano Instruments
- Veridex Acquires Immunicon
- Thermo Fisher Takes Over nAscent
- Labcyte and Deerac Fluidics Combine Operations
- Invitrogen and Applied Biosystems Merge to Form Life Technologies
- Insert Therapeutics Merges with Calando Pharmaceuticals
- Capsulution Nanoscience and NanoDel Technologies Merge
- BioForce Forms Collaboration with UAlbany NanoCollege
- Advion and Bruker Daltonik Enter into Joint Marketing Agreement
- Midatech Group Inks Agreement with MonoSol Rx
- Advion Signs Co-Marketing Agreement with Agilent Technologies
- Abraxis Inks Deal to Re-Acquire US Rights to Abraxane
- NanoKTN and Bio Nano to Develop Nanomedicine
- Evolved Machines Inks License Contract with Nanosys
- Abraxis Bags European Commission Approval to Market Abraxane
- Nanogen Eyes European Molecular Diagnostics Market
- Abraxis Receives Approval for Marketing ABRAXANE in Korea and China
- BioForce Receives MIT Validation for Nano eNabler Molecular Printer
- Oxonica and Becton, Dickinson and Co. Sign Strategic Deal
- Nanogen Sells Royalties to DRI Capital
- Nanogen Signs Deal with Thermo Fisher
- Midatech Establishes New Nanotechnology Subsidiary
- Nanogen and HX Diagnostics Extend Collaboration
- CytImmune Joins Hands with University of Maryland
- Abraxis Inks Licensing Deal with Japan's Taiho
- Abraxis Files Marketing Application for Abraxane in Japan
- BioForce Secures State Funding for ViriChip/li>
- Capsulution and Advanced Materials Ink Patent License Deal
- Midatech Bags US Grant on Patent Application
- Nanobiotix Wins European Patent for Activable Particles
- Nanotherapeutics Submits IND Application for NanoDOX Hydrogel
- Nanobiotix to Focus on Development of Diagnostics for Tropical Diseases
- Ceres to Develop Novel Nanotechnology Products
- Batist to Commence Production of Nanotechnology- Based Bandage
- Unidym Creates Spin-Off Unit
- Avanti Creates Dedicated Targeted Drug Delivery Company
- Hill-Rom Chooses Anti-Microbial Technology of NanoHorizons
- Advion Acquires NanoTek
- Pioneer Surgical Acquires Angstrom Medica
- Arrowhead Acquires C Sixty
- Veritek Completes Acquisition of Omni-Lite E-Form
- Wyeth Extends Collaboration with Ablynx
- Starpharma Inks Agreement with Stiefel
- Nanosys Signs Collaboration Deal with Bruker Daltonics
- Abraxis Selects Green Cross to Commercialize Abraxane in Korea
- Abraxis Signs Deal to Partner California NanoSystems Institute
- BioForce Nanosciences Inflates Clientele Base for Nano eNablerSystem
- Xidex Bags Contract to Make Carbon Nanotube Sources for Electron Microscopes
- Novartis Extends Deal with Ablynx
- BioSante Inks License Agreement with Medical Aesthetics
- NanoImaging Launches Imaging Services Unit
- Midatech Inaugurates cGMP Standard Nanoparticles Production Facility
- Abraxis Announces Dedicated Proprietary Biotechnology Business
- Eksigent Signs Distribution Deal in Brazil
- NanoVic Establishes Two Nano-bio Companies
- Veeco Signs Collaboration Deal with Leica
- NanoViricides Inks CRADA with USDoD Agency
- Rexahn Wins Maryland Industrial Partnerships Funding
- Azaya Therapeutics Gains Patent for Nanotech-Based Cancer Treatment Platform
- Flamel Inks Deal with Wyeth Pharmaceuticals
- Flamel Signs Deal with Merck Serono
- NanoChip 400 Platform of Nanogen Now a GSA Schedule Product
- Nanogen Bags Canadian Funding for Veterinary and Bio-Terror Diagnostics Development Project
- Nanogen Signs Deal in Australia for Schizophrenia Markers
- Wyeth Wins FDA Approval for New Labeling for Rapamune
- Arrowhead Infuses Capital into Tego
- GSK Extends Collaboration with Exelixis
- Oncologix Collaborates with Dendritic Nanotechnologies to Redesign its Oncosphere Product
- Abraxis Signs Licensing Contract in India
- Abraxis Receives Australian TGA's Acceptance to Review Marketing Application for Abraxane
- Nanotherapeutics and National Cancer Institute Sign CRADA
- Relisys and Cinvention Extend Licensing Agreement
- Lumera Extends Collaboration Pact with Medical University of South Carolina
- 9.FOCUS ON SELECT PLAYERS
- Abraxis BioScience, Inc. (US)
- Acusphere, Inc. (US)
- Advion Biosciences, Inc. (US)
- Agilent Technologies, Inc. (US)
- AMAG Pharmaceuticals, Inc. (US)
- Amgen, Inc. (US)
- Arrowhead Research Corporation (US)
- Calando Pharmaceuticals, Inc. (US)
- Nanotope, Inc. (US)
- Tego BioSciences Corporation (US)
- BioForce Nanosciences, Inc. (US)
- BioSante Pharmaceuticals, Inc. (US)
- Crucell N.V. (The Netherlands)
- Elan Corporation Plc (Ireland)
- Elan Drug Technologies (Ireland)
- Ensysce Biosciences, Inc. (US)
- Enzon Pharmaceuticals, Inc. (US)
- eSpin Technologies, Inc. (US)
- Flamel Technologies S.A. (France)
- Johnson & Johnson (US)
- Life Technologies Corporation (US)
- Merck & Co., Inc. (US)
- Nanobiotix (France)
- NanoCarrier Co., Ltd. (Japan)
- Nanospectra Biosciences, Inc. (US)
- Nanosphere, Inc. (US)
- Nanosys, Inc. (US)
- Nektar Therapeutics (US)
- Novavax, Inc. (US)
- Oxonica Plc (UK)
- Par Pharmaceutical Companies, Inc. (US)
- pSivida Limited (Australia)
- Starpharma Holdings Limited (Australia)
- Dendritic Nanotechnologies, Inc. (US)
- Starpharma Pty. Ltd. (Australia)
- Wyeth Pharmaceuticals, Inc. (US)
- 10.GLOBAL MARKET PERSPECTIVE
- Table 9: World Recent Past, Current & Future Analysis for Nanomedicine Market by Application Area - Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials and Other Applications Independently Analyzed with Annual Revenues in US$ Million for the Years 2006 through 2015 (includes corresponding Graph/Chart)
- Table 10: World 10-Year Perspective for Nanomedicine Market by Application Area - Percentage Breakdown of Revenues for Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials and Other Applications for the Years 2006, 2009 and 2015 (includes corresponding Graph/Chart)
- III. COMPETITIVE LANDSCAPE
- Total Companies Profiled: 263 (including Divisions/Subsidiaries - 269)
- Region/CountryPlayers
- The United States
- Canada
- Japan
- Europe
- France
- Germany
- The United Kingdom
- Spain6
- Rest of Europe19
- Asia-Pacific (Excluding Japan)
- Middle East8
